Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.

scientific article published on 30 August 2007

Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.MIB.2007.07.004
P698PubMed publication ID17765004

P50authorThierry NaasQ39652856
Laurent PoirelQ57551509
Patrice NordmannQ63214194
Nicolas FortineauQ114722294
P433issue5
P921main subjectPseudomonas aeruginosaQ31856
Staphylococcus aureusQ188121
multiple drug resistanceQ643839
P304page(s)436-440
P577publication date2007-08-30
P1433published inCurrent Opinion in MicrobiologyQ15752444
P1476titleSuperbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
P478volume10

Reverse relations

cites work (P2860)
Q64113656A Small RNA Transforms the Multidrug Resistance of Pseudomonas aeruginosa to Drug Susceptibility
Q33912745A high throughput flow cytometric assay platform targeting transporter inhibition
Q37743152A new vision of immunity: homeostasis of the superorganism
Q41965799Acanthamoeba and bacteria produce antimicrobials to target their counterpart.
Q26830053All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease
Q37726760Animals living in polluted environments are potential source of antimicrobials against infectious agents
Q41858535Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin
Q37077611Anti-infective antibodies: a novel tool to prevent and treat nosocomial diseases.
Q40090942Antimicrobial Activity of Bacillus amyloliquefaciens ANT1 Toward Pathogenic Bacteria and Mold: Effects on Biofilm Formation
Q37374748Antimicrobial resistance pattern of Gram-positive bacteria during three consecutive years at the nephrology ward of a tertiary referral hospital in Shiraz, Southwest Iran.
Q36571855Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung
Q43031037Bacteriophages as twenty-first century antibacterial tools for food and medicine
Q42577087Berberine-INF55 (5-nitro-2-phenylindole) hybrid antimicrobials: effects of varying the relative orientation of the berberine and INF55 components
Q40103359Characterization of the tertiary structure of the peptidoglycan of Enterococcus faecalis.
Q34775530Checks and balances: the ocular response to infection
Q28754911Daptomycin versus Friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responses
Q48137993Dermaseptin-PH: A Novel Peptide with Antimicrobial and Anticancer Activities from the Skin Secretion of the South American Orange-Legged Leaf Frog, Pithecopus (Phyllomedusa) hypochondrialis.
Q34365963Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital
Q37333114Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil
Q37228745Economics of antibiotic resistance
Q53173700Effect of organic matter on the in vitro photoeradication of Pseudomonas aeruginosa by means of a cationic tetraaryl-porphyrin.
Q90640517Evolution of antibiotic cross-resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window
Q38625299Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome
Q28392343Frequency and antibiotic susceptibility of gram-positive bacteria in Makkah hospitals
Q40506281Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana).
Q41216402Identification of small-molecule inhibitors against SecA by structure-based virtual ligand screening
Q38977280In Vitro Antibiofilm Efficacies of Different Antibiotic Combinations with Zinc Sulfate against Pseudomonas aeruginosa Recovered from Hospitalized Patients with Urinary Tract Infection
Q88764097Interaction of Bacterial Phenazines with Colistimethate in Bronchial Epithelial Cells
Q37318721Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond
Q43064053Marker removal in staphylococci via Cre recombinase and different lox sites
Q37233727Methicillin-resistant Staphylococcus aureus in Zimbabwe
Q33355620Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation
Q35202194Micropatterned surfaces for reducing the risk of catheter-associated urinary tract infection: an in vitro study on the effect of sharklet micropatterned surfaces to inhibit bacterial colonization and migration of uropathogenic Escherichia coli
Q48860089Modeling Pseudomonas aeruginosa pathogenesis in plant hosts.
Q28078930Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus
Q37329167New trends in pharmacogenomic strategies against resistance development in microbial infections
Q89473007Pharmacology of mangostins and their derivatives: A comprehensive review
Q35622545Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance
Q33745572Postgenomic strategies in antibacterial drug discovery.
Q36396130Prevention and treatment of virulent bacterial biofilms with an enzymatic nitric oxide-releasing dressing.
Q40772570Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections
Q27675215Promoter-Specific Transcription Inhibition in Staphylococcus aureus by a Phage Protein
Q33828309Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention
Q35014723RNA-Seq reveals differential gene expression in Staphylococcus aureus with single-nucleotide resolution
Q34086132Rapid detection of Pseudomonas aeruginosa from positive blood cultures by quantitative PCR
Q34775535Response of corneal epithelial cells to Staphylococcus aureus
Q61859168Roimatacene: An Antibiotic against Gram-Negative Bacteria Isolated from Cystobacter ferrugineus Cb G35 (Myxobacteria)
Q48313015Silver potentiates aminoglycoside toxicity by enhancing their uptake
Q37827872Strategies to manage antifungal drug resistance
Q27678149Structures of Helicobacter pylori Shikimate Kinase Reveal a Selective Inhibitor-Induced-Fit Mechanism
Q41159517Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa.
Q41496461Synthesis and Antibacterial Activity of Quaternary Ammonium 4-Deoxypyridoxine Derivatives
Q54419171Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases.
Q61439093Synthesis of Mono and Bis[60]fullerene-Based Dicationic Peptoids
Q38842620Tackling Threats and Future Problems of Multidrug-Resistant Bacteria
Q38761978The 'liaisons dangereuses' between iron and antibiotics.
Q58747314The serine/threonine kinase Stk and the phosphatase Stp regulate cell wall synthesis in Staphylococcus aureus
Q26782915The trans-kingdom identification of negative regulators of pathogen hypervirulence
Q41065747The use of local vancomycin powder in degenerative spine surgery
Q37137221Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue
Q61805091Variation in Mutant Prevention Concentrations
Q33850836War on terror cells: killing the host that harbours 'superbugs' is an infection control strategy in our fight against infectious diseases.

Search more.